Cyclophosphamide plus total body irradiation compared with busulfan plus cyclophosphamide as a conditioning regimen prior to hematopoietic stem cell transplantation in patients with leukemia: A systematic review and meta-analysis

Hematology/ Oncology and Stem Cell Therapy

Volumn 4, Issue 1, 2011, Pages 17-29

  Gupta, Tejpal ^a   Kannan, Sadhana ^a   Dantkale, Vandana ^a   Laskar, Siddharta ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; ASTHMA; BRONCHITIS; CANCER MORTALITY; CATARACT; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC MYELOID LEUKEMIA; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG EFFICACY; DRUG SAFETY; GROWTH DISORDER; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMORRHAGIC CYSTITIS; HUMAN; HYPOTHYROIDISM; INTERSTITIAL PNEUMONIA; LEUKEMIA RELAPSE; LIVER VENOOCCLUSIVE DISEASE; LOBAR PNEUMONIA; LUNG DISEASE; LUNG INFILTRATE; LUNG TOXICITY; MAJOR CLINICAL STUDY; MENTAL DISEASE; META ANALYSIS; MOTOR DYSFUNCTION; OVERALL SURVIVAL; PERCEPTION DISORDER; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK REDUCTION; SYSTEMATIC REVIEW; TREATMENT OUTCOME; WHOLE BODY RADIATION;

EID: 79956082295     PISSN: 16583876     EISSN: None     Source Type: Journal    
DOI: 10.5144/1658-3876.2011.17     Document Type: Article

References (45)

1. Gratwohl A, Baldomero H. Trends Of Hematopoi-Etic Stem Cell Transplantation In The Third Millen-Nium. Curr Opin Hematol 2009;16:420-6.
2. Copelan EA. Hematopoietic Stem-Cell Transplan-Tation. N Engl J Med 2006;354:1813-26.
3. Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb HJ, Rimm AA, Ringdén O, Roz-Man C, Speck B, et al. Graft-Versus-Leukemia Re-Actions After Bone Marrow Transplantation. Blood 1990;75:555-62.
4. Thomas ED, Storb R, Clift RA, Fefer A, Johnson L, Neiman PE, Lerner KG, Glucksberg H, Buckner CD. Bone-Marrow Transplantation (Second Of Two Parts). N Engl J Med 1975;292:895-902.
5. Brochstein JA, Kernan NA, Groshen S, Cir- Rincione C, Shank B, Emanuel D, Laver J, O'Reilly RJ. Allogeneic Bone Marrow Transplantation After Hyperfractionated Total-Body Irradiation And CyClophosphamide In Children With Acute Leukemia. N Engl J Med 1987;317:1618-24.
6. Santos GW, Tutschka PJ, Brookmeyer R, Saral R, Beschorner WE, Bias WB, Braine HG, Burns WH, Elfenbein GJ, Kaizer H, et al. Marrow Transplan-Tation For Acute Nonlymphocytic Leukemia After Treatment With Busulfan And Cyclophosphamide. N Engl J Med 1983;309:1347-53.
7. Tutschka PJ, Copelan EA, Klein J P. Bone Mar-Row Transplantation For Leukemia Following A New Busulfan And Cyclophosphamide Regimen. Blood 1987;70:1382-8.
8. Cosset JM, Socie G, Dubray B, Girinsky T, Fourquet A, Gluckman E. Single Dose Versus Fractionated Total Body Irradiation Before Bone Marrow Transplantation: Radiobiological And Clini-Cal Considerations. Int J Radiat Oncol Biol Phys 1994;30:477-92.
9. Sanders JE. Late Effects In Children Receiving Total Body Irradiation For Bone Marrow Transplan-Tation. Radiother Oncol 1990;18 Suppl 1:82-7.
10. Moreau P, Facon T, Attal M, Hulin C, Michallet M, Maloisel F, Sotto JJ, Guilhot F, Marit G, Doyen C, Jaubert J, Fuzibet JG, François S, Benboubker L, Monconduit M, Voillat L, Macro M, Berthou C, Dorvaux V, Pignon B, Rio B, Matthes T, Casas- Sus P, Caillot D, Najman N, Grosbois B, Bataille R, Harousseau JL; Intergorupe Francophone du Myélome. Comparison Of 200 Mg/M(2) Melphalan And 8 Gy Total Body Irradiation Plus 140 Mg/M(2) Melphalan As Conditioning Regimens For Peripheral Blood Stem Cell Transplantation In Patients With Newly Diagnosed Multiple Myeloma: Final Analysis Of The Intergroupe Francophone Du Myelome 9502 Randomized Trial. Blood 2002;99:731-5.
11. Michel G, Gluckman E, Esperou-Bourdeau H, Reiffers J, Pico JL, Bordigoni P, Thuret I, Blaise D, Bernaudin F, Jouet J P, et al. Allogeneic Bone Marrow Transplantation For Children With Acute Myeloblastic Leukemia In First Complete Remission: Impact Of Conditioning Regimen Without Total-Body Irradiation--A Report From The Societe Francaise De Greffe De Moelle. J Clin Oncol 1994;12:1217-22.
12. Granados E, De La Cámara R, Madero L, Díaz MA, Martín-Regueira P, Steegmann JL, Arranz R, Figuera A, Fernández-Rañada JM. Hematopoietic Cell Transplantation In Acute Lymphoblastic Leu-Kemia: Better Long Term Event-Free Survival With Conditioning Regimens Containing Total Body Irra-Diation. Haematologica 2000;85:1060-7.
13. Kim I, Park S, Kim Bk, Chang HM, Bang SM, Byun JH, Kim DJ, Min WS, Kim HJ, Kim CC. Al-Logeneic Bone Marrow Transplantation For Chronic Myeloid Leukemia: A Retrospective Study Of Busul-Fan-Cytoxan Versus Total Body Irradiation-Cytoxan As Preparative Regimen In Koreans. Clin Transplant 2001;15:167-72.
14. Kröger N, Zabelina T, Krüger W, Renges H, Stute N, Kabisch H, Jaburg N, Löliger C, Krüll A, Zander AR. Comparison Of Total Body Irradiation Vs Busulfan In Combination With Cyclophosphamide As Conditioning For Unrelated Stem Cell Transplan-Tation In CML Patients. Bone Marrow Transplant 2001;27:349-54.
15. Lahteenmaki PM, Chakrabarti S, Cornish JM, Oakhill AH. Outcome Of Single Fraction Total Body Irradiation-Conditioned Stem Cell Transplantation In Younger Children With Malignant Disease--Com-Parison With A Busulphan-Cyclophosphamide Regi-Men. Acta Oncol 2004;43:196-203.
16. Wingard JR, Plotnick L P, Freemer CS, Zahurak M, Piantadosi S, Miller DF, Vriesendorp HM, Yea-Ger AM, Santos GW. Growth In Children After Bone Marrow Transplantation: Busulfan Plus Cyclophos-Phamide Versus Cyclophosphamide Plus Total Body Irradiation. Blood 1992;79:1068-73.
17. Hartsell WF, Czyzewski EA, Ghalie R, KaiZer H. Pulmonary Complications Of Bone Marrow Transplantation: A Comparison Of Total Body Ir-Radiation And Cyclophosphamide To Busulfan And Cyclophosphamide. Int J Radiat Oncol Biol Phys 1995;32:69-73.
18. Michel G, Socié G, Gebhard F, Bernaudin F, Thuret I, Vannier J P, Demeocq F, Leverger G, Pico JL, Rubie H, Mechinaud F, Reiffers J, Gratecos N, Troussard X, Jouet J P, Simonin G, Gluckman E, Maraninchi D. Late Effects Of Allogeneic Bone Marrow Transplantation For Children With Acute My-Eloblastic Leukemia In First Complete Remission: The Impact Of Conditioning Regimen Without Total-Body Irradiation--A Report From The Societe Francaise De Greffe De Moelle. J Clin Oncol 1997;15:2238-46.
19. Holmstrom G, Borgstrom B, Calissendorff B. Cataract In Children After Bone Marrow Transplan-Tation: Relation To Conditioning Regimen. Acta Oph-Thalmol Scand 2002;80:211-5.
20. Smedler AC, Winiarski J. Neuropsychological Outcome In Very Young Hematopoietic SCT Recipi-Ents In Relation To Pretransplant Conditioning. Bone Marrow Transplant 2008;42:515-22.
21. Ringdén O, Labopin M, Tura S, Arcese W, Iriondo A, Zittoun R, Sierra J, Gorin NC. A Com-Parison Of Busulphan Versus Total Body Irradiation Combined With Cyclophosphamide As Conditioning For Autograft Or Allograft Bone Marrow Transplan-Tation In Patients With Acute Leukaemia. Acute Leukaemia Working Party Of The European Group For Blood And Marrow Transplantation (Ebmt). Br J Haematol 1996;93:637-45.
22. Davies SM, Ramsay NK, Klein JP, Weisdorf DJ, Bolwell B, Cahn JY, Camitta BM, Gale R P, Giralt S, Heilmann C, Henslee-Downey PJ, Herzig RH, Hutchinson R, Keating A, Lazarus HM, Milone GA, Neudorf S, Perez WS, Powles RL, Prentice HG, Schiller G, Socié G, Vowels M, Wiley J, Yeager A, Horowitz MM. Comparison Of Preparative Regi-Mens In Transplants For Children With Acute Lym-Phoblastic Leukemia. J Clin Oncol 2000;18:340-7.
23. Litzow MR, Pérez WS, Klein J P, Bolwell BJ, Camitta B, Copelan EA, Gale R P, Giralt SA, Keat-Ing A, Lazarus HM, Marks Di, Mccarthy PL, Miller Cb, Milone G, Prentice HG, Russell JA, Schultz KR, Trigg ME, Weisdorf DJ, Horowitz MM. Compari-Son Of Outcome Following Allogeneic Bone Mar-Row Transplantation With Cyclophosphamide-Total Body Irradiation Versus Busulphan-Cyclophospha-Mide Conditioning Regimens For Acute Myelog-Enous Leukaemia In First Remission. Br J Haematol 2002;119:1115-24.
24. Kanda Y, Sakamaki H, Sao H, Okamoto S, Kodera Y, Tanosaki R, Kasai M, Hiraoka A, Taka-Hashi S, Miyawaki S, Kawase T, Morishima Y, Kato S; Japan Marrow Donor Program. Effect Of Conditioning Regimen On The Outcome Of Bone Mar-Row Transplantation From An Unrelated Donor. Biol Blood Marrow Transplant 2005;11:881-9.
25. Uberti J P, Agovi MA, Tarima S, Haagenson M, Gandham S, Anasetti C, Baker KS, Bolwell BJ, Bornhauser M, Chan KW, Copelan E, Davies SM, Finke J, Hale GA, Kollman C, Mccarthy PL, Ratanatharathorn V, Ringdén O, Weisdorf DJ, Rizzo JD. Comparative Analysis Of Bu And Cy Versus Cy And Tbi In Full Intensity Unrelated Marrow Donor Transplantation For AML, CML And Myelodysplasia. Bone Marrow Transplant 2010.
26. Blaise D, Maraninchi D, Archimbaud E, et al. Allogeneic Bone Marrow Transplantation For Acute Myeloid Leukemia In First Remission: A Randomized Trial Of A Busulfan-Cytoxan Versus Cytoxan-Total Body Irradiation As Preparative Regimen: A Report From The Group d'Etudes De La Greffe De Moelle Osseuse. Blood 1992;79:2578-82.
27. Blaise D, Maraninchi D, Archimbaud E, Rei-Ffers J, Devergie A, Jouet JP, Milpied N, Attal M, Michallet M, Ifrah N, et al. Long-Term Follow-Up Of A Randomized Trial Comparing The Combination Of Cyclophosphamide With Total Body Irradiation Or Busulfan As Conditioning Regimen For Patients Receiving HLA-Identical Marrow Grafts For Acute Myeloblastic Leukemia In First Complete Remission. Blood 2001;97:3669-71.
28. Blume KG, Kopecky KJ, Henslee-Downey JP, Forman SJ, Stiff PJ, Lemaistre CF, Appelbaum FR. A Prospective Randomized Comparison Of Total Body Irradiation-Etoposide Versus Busulfan-Cyclo-Phosphamide As Preparatory Regimens For Bone Marrow Transplantation In Patients With Leukemia Who Were Not In First Remission: A Southwest On-Cology Group Study. Blood 1993;81:2187-93.
29. Clift RA, Buckner CD, Thomas ED, et al. Mar-Row Transplantation For Chronic Myeloid Leukemia: A Randomized Study Comparing Cyclophosphamide And Total Body Irradiation With Busulfan And Cyclo-Phosphamide. Blood 1994;84:2036-43.
30. Clift RA, Buckner CD, Thomas ED, Bensinger WI, Bowden R, Bryant E, Deeg HJ, Doney KC, Fish-Er LD, Hansen JA, et al. Long-Term Follow-Up Of A Randomized Study Comparing Cyclophosphamide And Total Body Irradiation With Busulfan And Cyclo-Phosphamide For Patients Receiving Allogenic Mar-Row Transplants During Chronic Phase Of Chronic Myeloid Leukemia. Blood 1999;94:3960-2.
31. Ringdén O, Ruutu T, Remberger M, Nikoske-Lainen J, Volin L, Vindeløv L, Parkkali T, Lenhoff S, Sallerfors B, Ljungman P, et al. A Randomized Trial Comparing Busulfan With Total Body Irradiation As Conditioning In Allogeneic Marrow Transplant Recipients With Leukemia: A Report From The Nor-Dic Bone Marrow Transplantation Group. Blood 1994;83:2723-30.
32. Ringdén O, Remberger M, Ruutu T, Nikoskel-Ainen J, Volin L, Vindeløv L, Parkkali T, Lenhoff S, Sallerfors B, Mellander L, Ljungman P, Jacobsen N. Increased Risk Of Chronic Graft-Versus-Host Dis-Ease, Obstructive Bronchiolitis, And Alopecia With Busulfan Versus Total Body Irradiation: Long-Term Results Of A Randomized Trial In Allogeneic Marrow Recipients With Leukemia. Nordic Bone Marrow Transplantation Group. Blood 1999;93:2196-201.
33. Dusenbery KE, Daniels KA, Mcclure JS, Mcglave PB, Ramsay NK, Blazar BR, Neglia JP, Kersey JH, Woods WG. Randomized Comparison Of Cyclophosphamide-Total Body Irradiation Versus Busulfan-Cyclophosphamide Conditioning In Au-Tologous Bone Marrow Transplantation For Acute Myeloid Leukemia. Int J Radiat Oncol Biol Phys 1995;31:119-28.
34. Devergie A, Blaise D, Attal M, Tigaud JD, Jou-Et JP, Vernant JP, Bordigoni P, Ifrah N, Dauriac C, Cahn JY, et al. Allogeneic Bone Marrow Transplan-Tation For Chronic Myeloid Leukemia In First Chronic Phase: A Randomized Trial Of Busulfan-Cytoxan Ver-Sus Cytoxan-Total Body Irradiation As Preparative Regimen: A Report From The French Society Of Bone Marrow Graft (SFGM). Blood 1995;85:2263-8.
35. Bunin N, Aplenc R, Kamani N, Shaw K, Cnaan A, Simms S. Randomized Trial Of Busulfan Vs Total Body Irradiation Containing Conditioning Regimens For Children With Acute Lymphoblastic Leukemia: A Pediatric Blood And Marrow Trans-Plant Consortium Study. Bone Marrow Transplant 2003;32:543-8.
36. Aschan J. Risk Assessment In Haematopoietic Stem Cell Transplantation: Conditioning. Best Pract Res Clin Haematol 2007;20:295-310.
37. Hartman AR, Williams SF, Dillon JJ. Survival, Disease-Free Survival And Adverse Effects Of Con-Ditioning For Allogeneic Bone Marrow Transplan-Tation With Busulfan/Cyclophosphamide Vs Total Body Irradiation: A Meta-Analysis. Bone Marrow Transplant 1998;22:439-43.
38. Socié G, Clift RA, Blaise D, Devergie A, Ringden O, Martin PJ, Remberger M, Deeg HJ, Ruutu T, Michallet M, Sullivan KM, Chevret S. Busulfan Plus Cyclophosphamide Compared With Total-Body Irradiation Plus Cyclophosphamide Before Mar-Row Transplantation For Myeloid Leukemia: Long-Term Follow-Up Of 4 Randomized Studies. Blood 2001;98:3569-74.
39. Shi-Xia X, Xian-Hua T, Hai-Qin X, Bo F, Xiang-Feng T. Total Body Irradiation Plus Cyclophospha-Mide Versus Busulphan With Cyclophosphamide As Conditioning Regimen For Patients With Leu-Kemia Undergoing Allogeneic Stem Cell Trans-Plantation: A Meta-Analysis. Leuk Lymphoma 2010;51:50-60.
40. Kato K, Khaled Y, Mineishi S. Reduced-Inten-Sity Stem Cell Transplantation For Hematological Malignancies: Current Status And The Future. Curr Stem Cell Res Ther 2007;2:149-62.
41. Stem Cell Trialists' Collaborative Group. Allo-Geneic Peripheral Blood Stem-Cell Compared With Bone Marrow Transplantation In The Management Of Hematologic Malignancies: An Individual Patient Data Meta-Analysis Of Nine Randomized Trials. J Clin Oncol 2005;23:5074-87.
42. Williams CB, Day SD, Reed MD, Copelan EA, Bechtel T, Leather HL, Wingard JR, Abbott BL, Abhyankar S, Mcguirk J P. Dose Modification Pro-Tocol Using Intravenous Busulfan (Busulfex) And Cyclophosphamide Followed By Autologous Or Allo-Geneic Peripheral Blood Stem Cell Transplantation In Patients With Hematologic Malignancies. Biol Blood Marrow Transplant 2004;10:614-23.
43. Pidala J, Kim J, Anasetti C, Kharfan-Dabaja MA, Nishihori T, Field T, Perkins J, Perez L, Fernan-Dez HF. Pharmacokinetic Targeting Of Intravenous Busulfan Reduces Conditioning Regimen Related Toxicity Following Allogeneic Hematopoietic Cell Transplantation For Acute Myelogenous Leukemia. J Hematol Oncol 2010;3:36.
44. Rosenthal J, Wong J, Stein A, Qian D, Hitt D, Naeem H, Dagis A, Thomas SH, Forman S. Phase I/Ii Trial Of Total Marrow And Lymph Node Irradiation To Augment Reduced Intensity Transplant For Ad-Vanced Hematological Malignancies. Blood 2010.
45. Lee SJ, Astigarraga CC, Eapen M, Artz AS, Da-Vies SM, Champlin R, Jagasia M, Kernan NA, Lo-Beriza FR Jr, Bevans M, Soiffer RJ, Joffe S. Varia-Tion In Supportive Care Practices In Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant 2008;14:1231-8.